366 related articles for article (PubMed ID: 17696907)
1. Investigation of intratumoural and peritumoural lymphatics expressed by podoplanin and LYVE-1 in the hybridoma-induced tumours.
Ji RC; Eshita Y; Kato S
Int J Exp Pathol; 2007 Aug; 88(4):257-70. PubMed ID: 17696907
[TBL] [Abstract][Full Text] [Related]
2. The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo.
Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mansel RE; Mason MD
Int J Mol Med; 2005 Oct; 16(4):723-8. PubMed ID: 16142411
[TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular mechanisms of lymphangiogenesis.
Al-Rawi MA; Mansel RE; Jiang WG
Eur J Surg Oncol; 2005 Mar; 31(2):117-21. PubMed ID: 15698725
[TBL] [Abstract][Full Text] [Related]
4. Lymphatics and D2-40/podoplanin expression in gastrointestinal stromal tumours of the stomach with and without lymph node metastasis: an immunohistochemical study with special reference to the Carney triad.
Agaimy A; Carney JA
J Clin Pathol; 2010 Mar; 63(3):229-34. PubMed ID: 20203222
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics.
Ji RC
Cancer Metastasis Rev; 2006 Dec; 25(4):677-94. PubMed ID: 17160713
[TBL] [Abstract][Full Text] [Related]
6. First year changes of myocardial lymphatic endothelial markers in heart transplant recipients.
Geissler HJ; Dashkevich A; Fischer UM; Fries JW; Kuhn-Régnier F; Addicks K; Mehlhorn U; Bloch W
Eur J Cardiothorac Surg; 2006 May; 29(5):767-71. PubMed ID: 16439147
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic vessels assessment in feline mammary tumours.
Sarli G; Sassi F; Brunetti B; Rizzo A; Diracca L; Benazzi C
BMC Cancer; 2007 Jan; 7():7. PubMed ID: 17222331
[TBL] [Abstract][Full Text] [Related]
8. The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status.
Sahni D; Robson A; Orchard G; Szydlo R; Evans AV; Russell-Jones R
J Clin Pathol; 2005 Jul; 58(7):715-21. PubMed ID: 15976338
[TBL] [Abstract][Full Text] [Related]
9. Mucocele: a human model for lymphangiogenesis.
Castro EC; Galambos C
Pediatr Dev Pathol; 2009; 12(3):222-8. PubMed ID: 18937525
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis.
Schledzewski K; Falkowski M; Moldenhauer G; Metharom P; Kzhyshkowska J; Ganss R; Demory A; Falkowska-Hansen B; Kurzen H; Ugurel S; Geginat G; Arnold B; Goerdt S
J Pathol; 2006 May; 209(1):67-77. PubMed ID: 16482496
[TBL] [Abstract][Full Text] [Related]
11. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer.
Williams CS; Leek RD; Robson AM; Banerji S; Prevo R; Harris AL; Jackson DG
J Pathol; 2003 Jun; 200(2):195-206. PubMed ID: 12754740
[TBL] [Abstract][Full Text] [Related]
12. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
[TBL] [Abstract][Full Text] [Related]
13. Homogeneity of mesothelial cells with lymphatic endothelium: expression of lymphatic endothelial markers by mesothelial cells.
Ando T; Jordan P; Wang Y; Jennings MH; Harper MH; Houghton J; Elrod J; Alexander JS
Lymphat Res Biol; 2005; 3(3):117-25. PubMed ID: 16190816
[TBL] [Abstract][Full Text] [Related]
14. Distribution of lymphatic vessels in mouse thymus: immunofluorescence analysis.
Odaka C; Morisada T; Oike Y; Suda T
Cell Tissue Res; 2006 Jul; 325(1):13-22. PubMed ID: 16541287
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
16. Multiple expressions of lymphatic markers and morphological evolution of newly formed lymphatics in lymphangioma and lymph node lymphangiogenesis.
Ji RC; Eshita Y; Xing L; Miura M
Microvasc Res; 2010 Sep; 80(2):195-201. PubMed ID: 20382171
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma.
Soares AB; Ponchio L; Juliano PB; de Araújo VC; Altemani A
J Clin Pathol; 2007 Sep; 60(9):995-1000. PubMed ID: 17079351
[TBL] [Abstract][Full Text] [Related]
18. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
Cursiefen C; Schlötzer-Schrehardt U; Küchle M; Sorokin L; Breiteneder-Geleff S; Alitalo K; Jackson D
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2127-35. PubMed ID: 12091407
[TBL] [Abstract][Full Text] [Related]
20. Correlation between lymphatic endothelial markers and lymph node status or N-staging of colorectal cancer.
Zhang XM; Han WX; Wang HY; He Q
World J Surg Oncol; 2017 Nov; 15(1):204. PubMed ID: 29162097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
